 age-rel differ hepat drug clearanc children studi lorazepam antipyrin disposit intraven antipyrin lorazepam model substrat hepat oxid metabol conjug children mean age year rang year acut lymphocyt leukemia complet remiss group ten healthi adult antipyrin clearanc weight children adult versu ml/min/kg differ surfac area contrast lorazepam total clearanc CL unbound clearanc clu weight differ children adult children surfac area CL versu clu versu mean lorazepam fraction unbound children differ adult volunt studi signific differ children adult disposit compound millilit minut clearanc antipyrin lorazepam